Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • /
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • People
  • US
  • UK
  • Germany
  • France
  • Africa
  • CH
  • @

Browsing Tag

KRAS

4 posts
RRoche
Roche, Asahi Kasei, Verastem—Fierce Pharma Asia
Read More

Roche, Asahi Kasei, Verastem—Fierce Pharma Asia

  • 2026-11-22
Roche extended its China shopping spree with a $1 billion-plus obesity deal. Asahi Kasei’s Hovilpri became the first…
RRoche
Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer
Read More

Roche’s divarasib demonstrated best-in-class efficacy, advancing the standard of care in previously treated KRAS G12C-mutated lung cancer

  • 2026-10-28
Divarasib monotherapy demonstrated superior efficacy over first-generation KRAS G12C inhibitors, lowering the risk of disease progression or death…
RRoche
Roche Reports Positive Results From Head-to-Head Study on NSCLC Drug
Read More

Roche Reports Positive Results From Head-to-Head Study on NSCLC Drug

  • 2026-07-03
Roche RHHBY reported positive results from the late-stage Krascendo 1 study evaluating experimental candidate, divarasib, in patients with…
RRoche
Roche KRAS drug succeeds in head-to-head lung cancer study
Read More

Roche KRAS drug succeeds in head-to-head lung cancer study

  • 2026-07-02
This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free…
Switzerland
www.europesays.com